Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Long-term Depression01:05

Long-term Depression

27.2K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
27.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular transformation of synthetic cannabinoids in surface water.

Ecotoxicology and environmental safety·2026
Same author

Controlling the Subpicosecond Coherent Spin and Valley Dynamics with Anomalous Magnetic Proximity Effect.

Physical review letters·2026
Same author

Comparison of Endoscopic Cap External Snare Resection (ECESR) and Endoscopic Muscularis Dissection (EMD) for Small Gastric Submucosal Tumors (≤ 12 mm) Emerging from the Muscularis propria.

Digestive diseases and sciences·2026
Same author

Occurrence, spatial distribution, and key determinants of typical herbicide residues in agricultural soils of northeast China.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Bias-Tunable GaN-Based Dual-Mode Photodiode Integrating Self-Powered Sensing and Synaptic Memory for Artificial Vision.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Subchronic exposure to environmental levels of fluoxetine disturbs gut microbiota-mediated intestinal barrier homeostasis and triggers delayed feeding response in zebrafish (Danio rerio).

Comparative biochemistry and physiology. Toxicology & pharmacology : CBP·2026

Related Experiment Video

Updated: Apr 24, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

9.4K

miR-137, a new target for post-stroke depression?

Lixia Zhao1, Huazi Li2, Ruiyou Guo3

  • 1Department of Neurology, Shandong Provincial Hospital, Jinan 250021, Shandong Province, China ; Department of Neurology, Haici Hospital Affiliated to Medical College of Qingdao University, Qingdao 266033, Shandong Province, China.

Neural Regeneration Research
|September 11, 2014
PubMed
Summary

MicroRNA-137 (miR-137) levels are lower in post-stroke depression. Restoring miR-137 inhibits depression by targeting Grin2A, offering a new therapeutic avenue for stroke patients.

Keywords:
Grin2Abrain injurycerebrovascular diseasemiR-137microRNAneural regenerationneuroregenerationpost-stroke depression

More Related Videos

Effect of Yi-Nao-Jie-Yu Prescription on Post-Stroke Depression in Rats using Middle Cerebral Artery Occlusion Combined with Behavioral Restraint
06:15

Effect of Yi-Nao-Jie-Yu Prescription on Post-Stroke Depression in Rats using Middle Cerebral Artery Occlusion Combined with Behavioral Restraint

Published on: January 9, 2026

181
Author Spotlight: Using Motor Imagery Brain-Computer Interface to Improve Motor and Cognitive Function in Stroke Patients
09:42

Author Spotlight: Using Motor Imagery Brain-Computer Interface to Improve Motor and Cognitive Function in Stroke Patients

Published on: September 1, 2023

2.6K

Related Experiment Videos

Last Updated: Apr 24, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

9.4K
Effect of Yi-Nao-Jie-Yu Prescription on Post-Stroke Depression in Rats using Middle Cerebral Artery Occlusion Combined with Behavioral Restraint
06:15

Effect of Yi-Nao-Jie-Yu Prescription on Post-Stroke Depression in Rats using Middle Cerebral Artery Occlusion Combined with Behavioral Restraint

Published on: January 9, 2026

181
Author Spotlight: Using Motor Imagery Brain-Computer Interface to Improve Motor and Cognitive Function in Stroke Patients
09:42

Author Spotlight: Using Motor Imagery Brain-Computer Interface to Improve Motor and Cognitive Function in Stroke Patients

Published on: September 1, 2023

2.6K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-137 (miR-137) is downregulated in depression and stroke.
  • The role of miR-137 in post-stroke depression remains unclear.

Purpose of the Study:

  • To investigate the role of miR-137 in a rat model of post-stroke depression.
  • To identify the molecular targets of miR-137 in this condition.

Main Methods:

  • Established a post-stroke depression rat model using middle cerebral artery occlusion and chronic mild stress.
  • Measured miR-137 levels in brain and blood.
  • Administered a miR-137 antagonist via intracerebroventricular injection.
  • Performed luciferase assays to confirm miR-137 binding to Grin2A mRNA.
  • Overexpressed Grin2A in the rat brain.

Main Results:

  • Post-stroke depression rats exhibited significantly lower miR-137 levels in the brain and blood.
  • miR-137 antagonist administration upregulated miR-137 and ameliorated depressive behaviors.
  • miR-137 directly targets the 3' untranslated region (3'UTR) of Grin2A.
  • Grin2A overexpression counteracted the antidepressant effects of miR-137.

Conclusions:

  • miR-137 acts as a suppressor of post-stroke depression by inhibiting Grin2A expression.
  • This miR-137/Grin2A pathway presents a novel therapeutic target for post-stroke depression.